articleThe LancetOct 1, 2015GREEN OA

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study

University of Miami · University of Florida · +17 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

666
total citations
FWCI
66.16
Percentile
100%
References
26
Citations per year

Authors

19

Topics & keywords

Keywords
  • Medicine
  • Internal medicine
  • Gastroenterology
  • Kidney disease
  • Chronic hepatitis
  • Stage (stratigraphy)
  • Virology
  • Virus
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding